alva is now Penta. We are the world’s first comprehensive stakeholder solutions firm. Learn More

Learn More

Hit enter to search or ESC to close

Get in touch

Pharma ESG report – March 2021 – May 2021

With the current drive to supply the world with vaccines, there is much greater interest and visibility on pharma firms’ product quality and safety than ever before. J&J (-39) and AstraZeneca’s (-25) scores decline from the previous quarter as both their COVID-19 vaccines are linked with blood clots.

Top performer Sanofi (+68) improves dramatically as it creates a non-profit unit to provide the poorest countries with access to essential medicinesBiogen (+63) receives the biggest quarter-on-quarter shift due to employee engagement and health & safety initiatives.

Download the full report here.